Herbas VPB

Print
EN | LT
LT - IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA
EN - IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61P 11/06 (2006.01)
A61K 39/3955 (2013.01)
A61K 39/395 (2006.01)
A61K 31/573 (2013.01)
A61K2039/505 (2013.01)
A61K2039/54 (2013.01)
A61K2039/545 (2013.01)
C07K2317/21 (2013.01)
C07K2317/76 (2013.01)
A61P 11/06 (2018.01)
C07K 16/2866 (2013.01)
European patent
(11) Number of the document 3703818
(13) Kind of document T
(96) European patent application number 18799655.8
Date of filing the European patent application 2018-10-29
(97) Date of publication of the European application 2020-09-09
(45) Date of publication and mention of the grant of the patent 2023-11-01
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2018/058039
Date 2018-10-29
PCT application publication
(87) Number WO 2019/089473
Date 2019-05-09
Priority applications
(30) Number Date Country code
201762579120 P 2017-10-30 US
201862710381 P 2018-02-16 US
201862647368 P 2018-03-23 US
18305566 2018-05-04 EP
201862742736 P 2018-10-08 US
Inventors
(72)
AMIN, Nikhil , US
GRAHAM, Neil , US
PIROZZI, Gianluca , US
TEPER, Ariel , US
Grantee
(73) Sanofi Biotechnology , 82 Avenue Raspail, 94250 Gentilly, FR
Regeneron Pharmaceuticals, Inc. , 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Title
(54) IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA
  IL-4R ANTAGONIST FOR USE IN A METHOD FOR TREATING OR PREVENTING ASTHMA